Comprehensive Tumor Genomic Profiling Panel (526 Genes, SNVs, Indels, Fusions, TMB, MSI) in UAE | 12000 AED | 2026 DHA Guidelines

تحليل لوحة الورم الجينومية الشاملة في الإمارات | 12000 درهم | معتمد من هيئة الصحة بدبي

ملخص تنفيذي

فحص جينومي متطور لـ 526 جيناً يشمل الطفرات النقطية والإدخالات الصغيرة والاندماجات الجينية وحجم الطفرات الورمية وعدم استقرار السواتل الميكروسكوبية. حساسية تشخيصية 99.9% عبر مختبر معتمد بمعايير ISO 9001:2015، مع خدمة سحب منزلي فاخرة ونقل مبرد، وإرشاد سريري هاتفي بعد النتيجة.

Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO Accredited Processing.
Premium Logistics: Paid Hospital-Grade Home Collection via ISO Certified Cold-Chain Home Collection and VIP Mobile Phlebotomy.
Clinical Guidance: Telephonic Post-Test Clinical Guidance in result interpretation by a DHA-licensed specialist.
Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.

Overview & Methodology

The Comprehensive Tumor Genomic Profiling Panel combines next-generation sequencing (NGS) analysis of 526 cancer-relevant genes with tumor mutational burden (TMB) and microsatellite instability (MSI) assessment, delivering actionable insights for personalized oncology. يقدم هذا التحليل الشامل بيانات قابلة للتنفيذ لعلاج الأورام الشخصي باستخدام أحدث تقنيات التسلسل الجيني.

Feature	Our Test – UAE Gold Standard	Closest Alternative
Gene Coverage	526 genes (full coding regions)	<50 hotspot regions
Alterations Detected	SNVs, Indels, Fusions, TMB, MSI	SNVs only, no TMB/MSI
Methodology	Next‑Generation Sequencing (NGS), ISO‑certified laboratory	PCR‑based limited genotyping
Turnaround Time	4 weeks (rigorous bioinformatics & expert review)	2–3 weeks (automated only)

Physician Insight & Safety Protocol

“As an oncologist, I recommend this comprehensive panel for patients with advanced or rare cancers when standard therapies have failed, but always correlate genomic findings with clinical and radiological data. لا توقف الدواء الموصوف دون استشارة طبيبك.”
— Dr. PRABHAKAR REDDY, DHA License: 61713011

Clinical Notice: Do not discontinue prescribed medication without consulting your doctor.

Exclusion Criteria & Red Flags

Test not indicated without a confirmed cancer diagnosis or valid clinical suspicion.
Insufficient FFPE tissue (tumor content <20%) may lead to inconclusive results.
ER Red Flags: Seek immediate medical attention if you experience severe pain, bleeding, swelling, or signs of infection at the biopsy site.

Patient FAQ & Clinical Guidance

1. What is the turnaround time for the Comprehensive Tumor Panel?

Results are typically delivered within 4 weeks from receipt of the FFPE tissue block, encompassing comprehensive sequencing and expert oncologist validation. This timeline ensures quality control, bioinformatics analysis, and a detailed report with therapeutic implications. In some cases, retesting of borderline samples may extend the period, and our support team will communicate any delays proactively.

تُصدر النتائج عادةً خلال 4 أسابيع من استلام عينة النسيج المضمنة بالبرافين، مع مراقبة جودة شاملة ومصادقة من أطباء الأورام المتخصصين.

2. Is this covered by UAE medical insurance?

Most major UAE insurers cover comprehensive genomic profiling when prescribed for an approved oncology indication, and our team verifies benefits before collection. We provide direct billing verification via WhatsApp at +971 54 548 8731, ensuring transparency and minimizing out-of-pocket costs. Always confirm your policy’s genetic testing clause, as coverage depends on the specific clinical scenario and insurer guidelines.

تغطي معظم شركات التأمين الكبرى في الإمارات الفحص الجينومي الشامل عند وصفه لدواعي أورام معتمدة، ويتولى فريقنا التحقق من التغطية قبل السحب.

3. How is my sample handled and is my genomic data kept confidential?

Your FFPE block is transported under ISO-certified cold-chain conditions, and all genomic data is encrypted and strictly protected under UAE PDPL and Federal Decree-Law No. 41 of 2024. Only authorized laboratory personnel process the sample, and results are shared exclusively with your ordering physician through a secure portal. We never store identifiable data longer than necessary and comply fully with Federal Law No. 3 of 2026 for minors and vulnerable groups.

تُنقل العينة وفق شهادة ISO بالنقل المبرد، وتُحفظ البيانات الجينية مشفرة ومحمية بموجب قانون حماية البيانات الشخصية الإماراتي والمرسوم الاتحادي رقم 41 لسنة 2024.

دعم ثنائي اللغة متاح